◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Gujarat Themis Biosyn Limited (GUJTHEM) Financial History

Name: Gujarat Themis Biosyn Limited (GUJTHEM) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Gujarat Themis Biosyn Limited (GUJTHEM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India. Its market capitalization is roughly ₹56 billion. In the fiscal year ended 2026-03-31, GUJTHEM reported ₹1.7B in revenue and ₹467M in net income.

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals, medicinal chemicals, and active pharmaceutical ingredients in India and internationally. The company offers bulk drugs on job work basis in India.

Interactive charts & full statements →

GUJTHEM Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹1.7B	₹1.5B	₹1.7B	₹1.5B	—
Gross Profit	₹1.4B	₹1.2B	₹1.3B	₹1.2B	—
Operating Income (EBIT)	₹648M	₹642M	₹756M	₹725M	—
Net Income	₹467M	₹488M	₹592M	₹580M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GUJTHEM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹438M	₹442M	₹434M	₹424M	₹359M	—	—
Gross Profit	₹384M	₹393M	₹361M	₹349M	₹279M	—	—
Operating Income (EBIT)	₹168M	₹153M	₹174M	₹180M	₹119M	—	—
Net Income	₹111M	₹109M	₹125M	₹143M	₹91M	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GUJTHEM Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹73M)	(₹18M)	(₹69M)	(₹124M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GUJTHEM Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹5.0B	₹3.0B	₹2.2B	₹1.7B	—
Total Liabilities	₹2.2B	₹529M	₹197M	₹172M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GUJTHEM viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

SPARC · Sun Pharma Advanced Research Company Limited — ₹63 billion
4886 · ASKA Pharmaceutical Holdings Co.,Ltd. — JPY 62 billion
IOLCP · IOL Chemicals and Pharmaceuticals Limited — ₹60 billion
FDC · FDC Limited — ₹57 billion
NOVARTIND · Novartis India Limited — ₹51 billion
ORCHPHARMA · Orchid Pharma Limited — ₹50 billion
4554 · Fuji Pharma Co., Ltd. — JPY 49 billion
RPGLIFE · RPG Life Sciences Limited — ₹46 billion

← GUJENERGY All “G” companies GULF →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.